Endothelial cell injury, as quantified by the soluble thrombomodulin level, predicts sepsis/multiple organ dysfunction syndrome after blunt trauma

Journal of Trauma - Injury, Infection and Critical Care

Volumn 44, Issue 5, 1998, Pages 789-795

  Ikegami, Keiichi ^a,b   Suzuki, Yoshihiko ^a   Yukioka, Tetsuo ^a   Matsuda, Hiroharu ^a   Shimazaki, Shuji ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYORIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOMODULIN;

ADULT; ARTICLE; BLUNT TRAUMA; CELL DAMAGE; CLINICAL ARTICLE; ENDOTHELIUM CELL; HUMAN; INFLAMMATORY DISEASE; INJURY SCALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

EID: 0031781268     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-199805000-00008     Document Type: Article

References (29)

1. Moore FA, Moore EE, Haenel JB. Post-injury multiple organ failure. In: Feliciano DV, Moore EE, Mattox KL, eds. Trauma. Stamford, Conn: Appleton & Lange; 1996:1205-1219.
2. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am. 1995;75:257-277.
3. Cipolle MD, Pasquale MD, Shearer J, Caldwell M, Cerra F. Blunt injury augments interleukin-6 but not tumor necrosis factor in isolated perfused rat hindlimbs. J Trauma. 1994; 37:91-99.
4. Maier RV, Bulger EM. Endothelial changes after shock and injury. New Horiz. 1996;4:211-223.
5. Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995;92:748-755.
6. Warner SJC, Auger KR, Libby P. Interleukin-1 induces interleukin 1. II Recombinant human interleukin 1 induces interleukin 1 production by adult human vascula endothelial cells. J Immunol. 1987;139:1911-1977.
7. Sironi M, Berviario F, Proserpio P, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol. 1989; 142:549-553.
8. Hebert CA, Luscinskas FW, Kiely JM, et al. Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J Immunol. 1990;145:3033-3034.
9. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest. 1985;76:2178-2181.
10. Ishii H. The detection and measurement of thrombomodulin. In: Gidings JC, ed. Thrombin, Thrombomodulin and the Control of Hemostasis. Austin, TX: RG Landes Company; 1994:121-141.
11. Kazama M. Soluble thrombomodulin: a specific parameter of endothelial injury. Jpn J Clin Hematol. 1991;32:103-137.
12. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cell. Thromb Haemost. 1991;65:618-623.
13. Takano S, Kimura S, Ohdarna S, Aoki N. Plasma thrombomodulin in health and diseases. Blood. 1990; 76:2024-20299.
14. Asakura H, Jokaji H, Saito M, et al. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Am J Hematol. 1991;38:281-287.
15. Gando S, Nakanishi Y, Kameue T, Nanzaki S, Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome alter trauma: role of neutrophil elastase. J Trauma. 1995;39:660-664.
16. Tanaka A, Ishii H, Hiraishi S, Kazama M, Maezawa H. Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin Chem. 1991;37:269-272.
17. Boehme MWJ, Schmitt WH, Youinou P, Stremmel WR, Gross WL. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitis. Am J Med. 1996;101:387-394.
18. Ohdama S, Takanno S, Miyake S, Kubota T, Sato K, Aoki N. Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. Am J Clin Pathol. 1994; 101:109-113.
19. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol. 1995; 90:244-248.
20. The Abbreviated Injury Scale - 1985 Revision. Des Paines, Ill: American Association for Automotive Medicine; 1985.
21. Knaus WA, Wanger DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critical ill hospitalized adults. Chest. 1991;100:1619-1636.
22. Members of the American College of Chest Physician/Society of Critical Care Medicine Consensus Conference. American College of Chest Physician/Society of Critical Care Medicine Consensus Conference: definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-874.
23. Faist E, Baue AE, Dittmer H, Heberer G. Multiple organ failure in polytrauma patients. J Trauma. 1983;23:775-787.
24. Kodama S, Uchijima E, Nagai M, Mikawatani K, Hayashi T, Suzuki K. One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies. Clin Chim Acta. 1990;192:191-200.
25. Verweij CL. Biosynthesis of human von Willebrand factor. Haemostasis. 1988;18:224-245.
26. Ruggeri ZM, Ware J. von Willebrand factor. FASEB J. 1993;7:308-316.
27. Ward PA, Varani J. Mechanisms of neutrophil-mediated killing of endothelial cells. J Leukoc Biol. 1990;48:97-102.
28. Hauser CJ, Zhou X, Joshi P, et al. The immune microenvironment of human fracture/soft-tissue hematomas and its relationship to systemic immunity. J Trauma. 1997; 42:895-904.
29. DiPietro LA. Wound healing: the role of the macrophage and other immune cells. Shock. 1995;4:233-240.